The Roles and Responsibilities of Pharmacovigilante’s in Adverse Drug Reaction Monitoring Centre
Rajalakshmi Rukmangathen1★, Brahmanapalli Vasundara Devi2, Dharini Bhoopathi2★ Corresponding author
- 1Adverse Drug Reaction Monitoring centre, Department of Pharmacology, Sri Venkateswara Medical College, Tirupati, Tamil Nadu, INDIA.
- 2Adverse Drug Reaction Monitoring centre, SDS Tuberculosis Research Centre & Rajiv Gandhi Institute of Chest Diseases, Bengaluru, Karnataka, INDIA.
CORRESPONDENCE
Rajalakshmi Rukmangathen
Adverse Drug Reaction Monitoring centre, Department of Pharmacology, Sri Venkateswara Medical College, Tirupati, Tamil Nadu, INDIA.
Volume 10, Issue 2 · pp. 137–141 · PUBLISHED · DOI: 10.5530/ijopp.10.2.28
ABSTRACT
Pharmacovigilante’s (PVLs) are highly trained, extra committed, dedicated professionals acting as the main link between patients and other healthcare professionals for better outcome in promoting safety of drugs. The process of drug safety monitoring and its outcomes will not only improve patient’s quality of life, but will also help in bringing changes in policies related to healthcare economics and other issues of national importance. National and regional Pharmacovigilance (PV) systems are well-adapted bodies, attuned to the intricate collection and analysis of ADR data that leads to timely alerts and interventions to protect population health. The adverse events reported by PVLs to PV system will potentially benefit to the community due to their proximity to both the population and public health practitioners. This article overviews the functions of PVLs in the context of their roles and responsibilities in the Pharma-covigilance Programme of India working in an adverse drug reaction monitoring centre (AMCs) mainly focusing on promotional activities of PVPI.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Rukmangathen, R., Devi, B. V., & Bhoopathi, D. (). The Roles and Responsibilities of Pharmacovigilante’s in Adverse Drug Reaction Monitoring Centre. Indian Journal of Pharmacy Practice, 10(2), 137–141. https://doi.org/10.5530/ijopp.10.2.28
